Study Name: Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breas
18 locations found
- Study Name Unavailable
Location: Greenbrae, California 94904
- Study Name Unavailable
Location: Sylmar, California 91342
- Study Name Unavailable
Location: West Palm Beach, Florida 33401
- Study Name Unavailable
Location: Joliet, Illinois 60435
- Study Name Unavailable
Location: Evansville, Indiana 47713
- Study Name Unavailable
Location: Louisville, Kentucky 40207
- Study Name Unavailable
Location: Boston, Massachusetts 02114
- Study Name Unavailable
Location: Jackson, Mississippi 39202
- Study Name Unavailable
Location: Springfield, Missouri 65804
- Study Name Unavailable
Location: Albuquerque, New Mexico 87131
- Study Name Unavailable
Location: Lake Success, New York 11042
- Study Name Unavailable
Location: Durham, North Carolina 27710
- Study Name Unavailable
Location: Philadelphia, Pennsylvania 19104
- Study Name Unavailable
Location: Bristol, Tennessee 37620
- Study Name Unavailable
Location: Memphis, Tennessee 38120
- Study Name Unavailable
Location: El Paso, Texas 79905
- Study Name Unavailable
Location: Burlington, Vermont 05405
- Study Name Unavailable
Location: Madison, Wisconsin 53792
|